1
|
Jiang JJ, Gao C, Mao JF, Yang GY, Huang J, Yu XH, Tan Y, Zhang JC, Zheng XF. Effect of endoscopic therapy and drug therapy on prognosis and rebleeding in patients with esophagogastric variceal bleeding. Sci Rep 2024; 14:7364. [PMID: 38548903 PMCID: PMC10978843 DOI: 10.1038/s41598-024-57791-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Accepted: 03/21/2024] [Indexed: 04/01/2024] Open
Abstract
Esophagogastric variceal bleeding (EVB) is one of the common digestive system emergencies with poor prognosis and high rate of rebleeding after treatment. To explore the effects of endoscopic therapy and drug therapy on the prognosis and rebleeding of patients with EVB, and then select better treatment methods to effectively improve the prognosis. From January 2013 to December 2022, 965 patients with EVB who were hospitalized in gastroenterology Department of the 940 Hospital of Joint Logistic Support Forces of PLA were retrospectively analyzed. Patients were divided into endoscopic treatment group (ET, n = 586) and drug treatment group (DT, n = 379). Propensity score matching (PSM) analysis was performed in both groups, and the general information, efficacy and length of hospital stay were recorded. The patients were followed up for 3 months after bleeding control to determine whether rebleeding occurred. There were 286 cases in each group after PSM. Compared with DT group, ET had higher treatment success rate (P < 0.001), lower rebleeding rate (P < 0.001), lower mortality rate within 3 months, and no significant difference in total hospital stay (P > 0.05). Compared with drug therapy, endoscopic treatment of EVB has short-term efficacy advantages, and can effectively reduce the incidence of rebleeding and mortality within 3 months.
Collapse
Affiliation(s)
- Jing-Jing Jiang
- Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Forces of PLA, Qilihe District, 333Rd Binhenan Road, Lanzhou, 730050, Gansu, China
- The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China
| | - Chun Gao
- Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Forces of PLA, Qilihe District, 333Rd Binhenan Road, Lanzhou, 730050, Gansu, China
- The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China
| | - Jun-Feng Mao
- Department of Nuclear Medicine, The 940 Hospital of Joint Logistic Support Forces of PLA, Lanzhou, 730050, Gansu, China
| | - Guo-Yuan Yang
- The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China
| | - Jun Huang
- Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Forces of PLA, Qilihe District, 333Rd Binhenan Road, Lanzhou, 730050, Gansu, China
- The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, China
| | - Xiao-Hui Yu
- Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Forces of PLA, Qilihe District, 333Rd Binhenan Road, Lanzhou, 730050, Gansu, China
| | - Yong Tan
- Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Forces of PLA, Qilihe District, 333Rd Binhenan Road, Lanzhou, 730050, Gansu, China
| | - Jiu-Cong Zhang
- Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Forces of PLA, Qilihe District, 333Rd Binhenan Road, Lanzhou, 730050, Gansu, China.
| | - Xiao-Feng Zheng
- Department of Gastroenterology, The Second Hospital of Lanzhou University, Lanzhou, 730030, Gansu, China.
| |
Collapse
|